Related Experiment Video
Updated: Aug 8, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Stenotrophomonas maltophilia peritonitis in a patient receiving automated peritoneal dialysis
Eduardo Machuca1, Ana M Ortiz, Ricardo Rabagliati
1Department of Nephrology, P. Catholic University, Santiago, Chile.
Abstract:
Stenotrophomonas maltophilia is increasingly being recognized as an important cause of nosocomial infection. S. maltophilia peritonitis is a rare complication of chronic peritoneal dialysis. Here, we report the case of a 54-year-old female with end-stage renal disease treated with automated peritoneal dialysis. The patient had no previous history of peritonitis or catheter exit-site infection. She presented with fever, abdominal pain, and cloudy peritoneal effluent. The organism isolated from the effluent was S. maltophilia. The patient received trimethoprim 320 mg and sulfamethoxazole 1600 mg for 6 weeks, plus amikacin 200 mg for 14 days. She recovered completely, with no need for catheter removal. No recurrence was observed.
Insights
Stenotrophomonas maltophilia peritonitis is a rare complication in patients undergoing chronic peritoneal dialysis. This case study shows successful treatment with antibiotics, avoiding catheter removal.
Area of Science:
- Infectious Diseases
- Nephrology
- Microbiology
Background:
- Nosocomial infections caused by Stenotrophomonas maltophilia are a growing concern.
- Peritonitis is a rare but serious complication for patients on chronic peritoneal dialysis.
- End-stage renal disease necessitates renal replacement therapy, such as peritoneal dialysis.
Observation:
- A 54-year-old female on automated peritoneal dialysis presented with fever, abdominal pain, and cloudy effluent.
- No prior history of peritonitis or catheter exit-site infection was noted.
- Stenotrophomonas maltophilia was identified as the causative agent in the peritoneal effluent.
Findings:
- The patient was treated with a combination of trimethoprim/sulfamethoxazole for six weeks and amikacin for 14 days.
- Complete recovery was achieved without the need for peritoneal dialysis catheter removal.
- No recurrence of S. maltophilia peritonitis was observed during follow-up.
Implications:
- This case highlights the successful management of Stenotrophomonas maltophilia peritonitis in a peritoneal dialysis patient.
- Antibiotic therapy alone can be effective, potentially avoiding catheter removal in select cases.
- Early recognition and appropriate antimicrobial treatment are crucial for favorable outcomes in S. maltophilia peritonitis.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis I: Introduction and Procedure
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Kidney Injury V: Interprofessional Care
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure
